Local Institution - 2107

Houston, Texas 77030

0 studies enrolling now · 1 studies all time

What they study most

Advanced Solid Tumor, KRAS Mutation-Related Tumors, Metastatic Solid Tumor

Studies at this site

• A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors — Stopped early